Latest Mergers And Acquisitions News

Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.

Leeuwin Metals continues to expand its Marda Gold Project resource with promising shallow gold intercepts at Evanston and Golden Orb, while assays for additional holes remain pending ahead of May drilling resumption.

Solis Minerals has expanded its lithium footprint with a fresh acquisition in Brazil, setting the stage for a busy drilling calendar across lithium and copper assets in South America.

Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.

Sunstone Metals reported robust growth at its Bramaderos gold-copper project with a 3.6Moz AuEq resource and substantial exploration targets. Drilling at Copete and Porotillo prospects confirmed mineralisation continuity, underpinning potential resource upgrades.

TechGen Metals has reported a standout 20m @ 1.14% copper intercept at Mt Boggola and secured key drilling approvals at Blue Devil, setting the stage for multiple exploration campaigns in 2026.

Adveritas Limited surged to $15.08 million ARR, up 91% year-on-year, powered by a new self-serve SME platform and AI-driven product enhancements.

Renowned boosts its US footprint with a landmark RE/MAX partnership and expands multi-year brokerage deals in Australia and New Zealand, driving 3% group revenue growth and positive cash flow in Q3 FY26.

Racura Oncology reported robust progress in Q3 FY2026, including launching a key lung cancer trial and unveiling a novel blood test for cardioprotection, supported by a solid $19.38 million cash position.

Reach Resources has boosted its Blue Heaven gold resource by roughly 30% to 80,000 ounces, supported by strong metallurgical results and a newly granted mining lease, while progressing a $3.15 million rights issue to fund further exploration and development.

Optiscan Imaging has submitted its FDA dossier for InSpecta®, marking a crucial step toward US veterinary market entry, while progressing clinical studies for InVue® and InForm® ahead of further FDA submissions in 2026.

hipages Group has acquired a majority stake in VIZ Insurance, marking its strategic entry into the insurance sector for tradies and broadening its platform offerings.